INCAP will attend Vitafoods Europe 2026 in Barcelona together with Goodwill Pharma PLC, where the companies will present new functional beverage concepts based on INCAP’s dosing cap technology.

At the show, Goodwill Pharma will introduce its Fortacell ready-to-drink range, a product platform developed around freshly activated powder-to-drink beverages. According to the product information, the Fortacell concept is designed as one brand with multiple solutions and includes product concepts in immunity, sport, hydration, energy, beauty, metabolic support and sleep. The range is built around a simple turn, push and shake activation process that releases dry ingredients at the moment of use

The presentation at Vitafoods Europe will also include a creatine shot concept developed with INCAP technology. This product highlights how dosing cap systems can support beverage formats where ingredient protection, on-demand mixing and consumer experience play an important role.

The Fortacell concept positions the format around fresh activation, precise formulation and ease of use. In the product materials, Goodwill Pharma also emphasizes the commercial advantages of the platform, including strong shelf differentiation, convenient ready-to-drink use and the ability to build multiple SKUs within one system

For INCAP, the joint presence at Vitafoods Europe reflects the increasing market interest in beverage solutions that combine functional ingredients with a more dynamic and differentiated packaging concept. By keeping sensitive ingredients separated until consumption, dosing cap technology can open new possibilities for product development in nutraceuticals and functional drinks.

Visitors are invited to meet the teams at Booth 6H68 during Vitafoods Europe 2026, taking place in Barcelona from 05–07 May 2026.